Bicycloamine carboxamide derivative
AssigneeSumitomo Pharma Co., Ltd.
InventorsYuta FUNAKOSHI, Eiji IDEUE, Keita SAKAMOTO, Masafumi KOMIYA, Riko NAGAHAMA
Life of this patent
Estimating the term…
Loading patent…
AssigneeSumitomo Pharma Co., Ltd.
InventorsYuta FUNAKOSHI, Eiji IDEUE, Keita SAKAMOTO, Masafumi KOMIYA, Riko NAGAHAMA
Estimating the term…
The present invention relates to a compound of formula (1) or a pharmaceutically acceptable salt thereof with therapeutic and prophylactic effects for a disease associated with orexin receptor type 2, specifically, a disease such as narcolepsy, idiopathic hypersomnia, hypersomnia, sleep apnea syndrome, wherein R1 and R2 are each independently hydrogen atom, etc.; R3 and R4 are each independently hydrogen atom, etc.; R5 is optionally-substituted C1-4 alkyl; -L1-ring G is -ring G, —CH2-ring G, etc.; R6 is each independently hydrogen atom, etc.; n is an integer of 1 or 2; ring G is optionally-substituted C6-10 aromatic carbocyclyl group, etc.; A1 is oxygen atom, etc.; A2 is oxygen atom, etc.; j, k, l, and m are each independently an integer of 0, 1, or 2; dashed bond is single bond or double bond; X is —CR7—, etc.; R7 is hydrogen atom, etc.; and ring E is formula (1a-1), (1a-2), or (1a-3).
A compound of formula (1):
A medicament for treating narcolepsy, idiopathic hypersomnia, hypersomnia, sleep apnea syndrome, narcolepsy syndrome involving narcolepsy-like symptom, hypersomnia associated with Parkinson's disease, or hypersomnia associated with dementia with Lewy body, comprising the compound according to any one of Items 1 to 16 or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.